Welcome & Introduction

Ideal Investigation Pathway for Renal Cell Carcinoma

Best Abstracts in Clinical value ASCO GU 2022 Update

Welcome & Introduction

Newer Neo & Adjuvant treatment options in NSCLC

Recent Advances in Targeted therapy for metastatic Lung Cancer

Welcome & Introduction

Lorlatinib as front Line option in ALK+ mNSCLC

Meeting the unmet need in NSCLC patients with MET exon 14 alterations

Welcome & Introduction

Role of Adjuvant Radiotherapy in Curable Gastric Maglignancies

Debate FLOT Protocol for AII Localy Advanced GE Junction Tumours

Welcome & Introduction

SURGICAL OUTCOMES FROM THE PHASE 3 CHECKMATE 816 TRIAL

Neoadjuvant Pembrolizumab for Early Stage Non Small Cell Lung Cancer